logo

Roche Holding Ag (RHHBY)



Trade RHHBY now with
  Date
  Headline
7/17/2018 1:02:23 AM Genentech Says Phase III CAPSTONE-2 Study Assessing Safety And Efficacy Of Baloxavir Marboxil Meets Primary Objective
7/12/2018 1:03:02 AM Genentech Announces Submission Of Supplemental New Drug Application For Venclexta
7/2/2018 1:02:33 AM Genentech Says Phase III IMpassion130 Study Meets Co-primary Endpoint Of Progression Free Survival
6/26/2018 2:03:41 AM Genentech Says FDA Granted Priority Review To Baloxavir Marboxil For Treatment Of Influenza
6/25/2018 1:01:49 AM Genentech Says Phase III IMpower133 Study Meets Co-primary Endpoints Of Overall Survival And PFS
6/22/2018 1:06:23 AM Roche Announces Changes To Corporate Executive Committee
6/19/2018 7:03:21 AM University Of Missouri School Of Medicine, Roche Collaborate On First US Implementation Of Tumor Board Software
6/14/2018 1:02:13 AM Genentech Announces New OCREVUS Data On Long-Term Disability Benefits In Primary Progressive Multiple Sclerosis
6/11/2018 7:02:03 AM Roche Announces Plans To Launch The CoaguChek Vantus System
6/8/2018 3:09:15 PM Genentech Gets FDA Approval For Venclexta Plus Rituxan For People With Previously Treated Chronic Lymphocytic Leukemia
6/7/2018 8:42:08 AM Roche To Showcase New Solutions To Consolidate Automated Molecular Testing, Microbiology Topics At ASM Microbe 2018